NASDAQ:OGI

Organigram Global Q4 2026 Earnings Date & Estimates

Organigram Global logo
$0.60 -0.03 (-4.76%)
As of 03:59 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Organigram Global is estimated to report Q4 2026 earnings on Tuesday, December 15, 2026, before market opens. The conference call is scheduled for 9:30 AM ET.

Upcoming Earnings Announcement

Quarter
Q4 2026
Announcement Date
Time
Before Market Opens
Conference Call
9:30 AM ET

What Analysts Expect from Organigram Global in Q4 2026

Organigram Global is expected to post earnings of $0.02 per share on revenue of $84.67 million. In the same quarter a year earlier Organigram Global reported -$0.20 per share on revenue of $57.53 million. Organigram Global last reported on May 12, 2026, posting -$0.01 per share and matching the -$0.01 consensus estimate. Organigram Global has beaten the consensus EPS estimate in 1 of its last 8 quarters.

Consensus Estimates

Consensus EPS
$0.02
Expected Revenue
$84.67 million
Prior-Year EPS
-$0.20
Prior-Year Revenue
$57.53 million
Expected Revenue Growth
+47.2%

Recent Track Record

Last Reported
Q2 2026
Last Quarter EPS
-$0.01 (Met Expectations)
Last Quarter Revenue
$42.99 million
EPS Beat Rate
1 of last 8 quarters

Organigram Global Q4 2026 Earnings FAQ

Organigram Global (NASDAQ:OGI) is estimated to report Q4 2026 earnings on Tuesday, December 15, 2026, before market opens. This date is estimated from past reporting schedules and may change once the company confirms it.

Organigram Global's Q4 2026 earnings conference call is scheduled for Tuesday, December 15, 2026 at 9:30 AM ET. MarketBeat streams the conference call audio and posts the transcript as soon as possible on the earnings announcement date.

Analysts expect Organigram Global to post earnings of $0.02 per share for Q4 2026.

The consensus revenue estimate for Organigram Global is $84.67 million for Q4 2026.

Organigram Global Earnings Headlines

Organigram Provides NASDAQ Listing Update
Beyond NVDA: The World’s Next #1 Company?
This small-cap trades in an overlooked corner of the market, with a market cap more than 600X smaller than Nvidia's. A NASA scientist says the technology behind it is bigger than AI. Musk calls it "Amazing," and a Nobel Prize winner describes its power as "unprecedented in the history of life on Earth." Adam O'Dell, Chief Investment Strategist at Money and Markets, names the company at the center of it all.tc pixel
Transcript : Organigram Global Inc. - Special Call
See More Organigram Global Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Organigram Global? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Organigram Global and other key companies, straight to your email.

About Organigram Global

Organigram Global (NASDAQ:OGI) is a Canadian cannabis company that cultivates, processes and sells cannabis and cannabinoid products. Its offerings include dried flower, pre-rolls, edibles, vape products, concentrates and cannabis-infused beverages, sold under brands such as Edison, SHRED, Big Bag O’ Buds and BOXHOT.

The company traces its roots to Organigram, a licensed cannabis producer established in New Brunswick. It expanded its portfolio and manufacturing capabilities through acquisitions, including the 2024 purchase of Canadian cannabis company Motif Labs.

Organigram primarily serves Canada’s adult-use cannabis market and also supplies medical cannabis and exports to select international markets. Its operations and products span multiple parts of the Canadian cannabis supply chain, from cultivation and processing to product development and distribution.

View Organigram Global Profile